Conduit Pharmaceuticals Quote - CDT

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

2.42

Bid

2.35

Ask

2.45

Volume

246,249

2.35 Day's Range 2.5605

2.35 52 Week Range 392.00

Market Cap

248.892M

Previous Close

2.55

Open

2.54

Last Trade

2.42

Last Trade Time

Financial Volume

US$ 605,321

VWAP

2.4582

Average Volume (3m)

55,913,310

Shares Outstanding

102,847,973

Dividend Yield

PE Ratio

-286.08

Earnings Per Share (EPS)

-0.06

Revenue

Net Profit

-6.06M

Conduit Pharmaceuticals, Inc. is a disease agnostic life science company. The Company is engaged in the development and commercialization of clinical assets to address the unmet medical needs of patients. The Company's licensed clinical assets are focused on idiopathic male infertility and autoimmun... Conduit Pharmaceuticals, Inc. is a disease agnostic life science company. The Company is engaged in the development and commercialization of clinical assets to address the unmet medical needs of patients. The Company's licensed clinical assets are focused on idiopathic male infertility and autoimmune diseases or immunodeficient conditions like uveitis, preterm labor, renal transplant rejection and Hashimoto's Thyroiditis. The Company's asset pipeline includes AZD1656 (a Glucokinase Activator), and AZD5904 (a Myeloperoxidase Inhibitor). AZD1656 is a glucokinase activator used in diabetes mellitus. It is used as a treatment option for Hashimoto's Thyroiditis (HT) and Graves' disease, including investigating any negative side effects of the use of AZD1656 as compared with treatment options for Hashimoto's Thyroiditis and Graves' disease. AZD5904 includes a potent, irreversible inhibitor of human myeloperoxidase (MPO), that has the potential to treat Idiopathic Male Infertility (IMI). Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.conduitpharma.com

Headquarters

Wilmington, Delaware, USA

Founded

Conduit Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CDT. The last closing price for Conduit Pharmaceuticals was US$2.55. Over the last year, Conduit Pharmaceuticals shares have traded in a share price range of US$ 2.35 to US$ 392.00.

Conduit Pharmaceuticals currently has 102,847,973 shares outstanding. The market capitalization of Conduit Pharmaceuticals is US$262.26 million. Conduit Pharmaceuticals has a price to earnings ratio (PE ratio) of -286.08.

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Conduit is planning how to effectively integrate an advanced platform-driven approach powered by artificial intelligence and cybernetics to expedite drug development, while continuing to advance...

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a multi-asset, clinical stage...

Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for its Autoimmune Pipeline

Award-winning Agility Life Sciences brings a proven track record in drug formulation for a number of pharmaceutical and biotechnology clients. NAPLES, Fla. and CAMBRIDGE, United Kingdom, Jan...

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Conduit Pharmaceuticals partners with SARBORG Limited to leverage artificial intelligence and cybernetics for optimizing key drug development processes, including drug repurposing, discovery, and...

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit" or the “Company”) today announced...

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

Conduit Pharmaceuticals strengthens its Board of Directors with the addition of Simon Fry, a seasoned investment banking executive with over 30 years of experience in asset management, capital...

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

SAN DIEGO and LONDON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), today announced the restructuring of a portion of its financial...

Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

SAN DIEGO and LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), today announced it will be participating in the H.C. Wainwright...

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Conduit Pharmaceuticals announces plans to initiate Phase 2a trials in both systemic lupus erythematosus and ANCA-associated vasculitis for its lead clinical candidate, AZD1656AZD1656, a HK-4...

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

Conduit Pharmaceuticals enters into exclusive license agreement with AstraZeneca for HK-4 Glucokinase activators AZD1656 and AZD5658 targeting autoimmune indications and myeloperoxidase inhibitor...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.58	-39.5	4	5.839	2.35	6192140	4.23166631	CS
4	-5.105	-67.8405315615	7.525	18.32	2.35	114799075	10.6713096	CS
12	-7.58	-75.8	10	18.32	2.35	55913310	10.29596047	CS
26	-19.2	-88.8066604995	21.62	41.5	2.35	34456039	11.35026535	CS
52	-272.58	-99.12	275	392	2.35	17939521	12.1988844	CS
156	-1257.58	-99.8079365079	1260	1289	2.35	13365436	14.19489122	CS
260	-1257.58	-99.8079365079	1260	1289	2.35	13365436	14.19489122	CS

CDT - Frequently Asked Questions (FAQ)

What is the current Conduit Pharmaceuticals share price?

The current share price of Conduit Pharmaceuticals is US$ 2.42

How many Conduit Pharmaceuticals shares are in issue?

Conduit Pharmaceuticals has 102,847,973 shares in issue

What is the market cap of Conduit Pharmaceuticals?

The market capitalisation of Conduit Pharmaceuticals is USD 262.26M

What is the 1 year trading range for Conduit Pharmaceuticals share price?

Conduit Pharmaceuticals has traded in the range of US$ 2.35 to US$ 392.00 during the past year

What is the PE ratio of Conduit Pharmaceuticals?

The price to earnings ratio of Conduit Pharmaceuticals is -286.08

What is the reporting currency for Conduit Pharmaceuticals?

Conduit Pharmaceuticals reports financial results in USD

What is the latest annual profit for Conduit Pharmaceuticals?

The latest annual profit of Conduit Pharmaceuticals is USD -6.06M

What is the registered address of Conduit Pharmaceuticals?

The registered address for Conduit Pharmaceuticals is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the Conduit Pharmaceuticals website address?

The website address for Conduit Pharmaceuticals is www.conduitpharma.com

Which industry sector does Conduit Pharmaceuticals operate in?

Conduit Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TCTMTCTM Kids IT Education Inc	US$ 0.764 (321.87%)	729.72M
REBNReborn Coffee Inc	US$ 3.31 (63.05%)	55.54M
FCUVFocus Universal Inc	US$ 5.87 (56.62%)	1.73M
SOPASociety Pass Inc	US$ 1.54 (56.50%)	13.82M
CYCNCyclerion Therapeutics Inc	US$ 3.92 (54.33%)	82.39M
ENVBEnveric Biosciences Inc	US$ 2.0899 (-46.41%)	1.57M
NIVFNewGenIvf Group Ltd	US$ 0.1489 (-42.51%)	14.8M
GLSTGlobal Star Acquisition Inc	US$ 8.83 (-39.10%)	23.89k
PRPHProPhase Labs Inc	US$ 0.2633 (-38.02%)	872.46k
SPGCSacks Parente Golf Inc	US$ 0.5601 (-37.86%)	7.27M
TCTMTCTM Kids IT Education Inc	US$ 0.764 (321.87%)	729.72M
NVDANVIDIA Corporation	US$ 120.07 (-3.67%)	388.54M
RIMEAlgorhythm Holdings Inc	US$ 0.02565 (5.12%)	338.75M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.0355 (-11.25%)	236.29M
CLEUChina Liberal Education Holdings Ltd	US$ 0.1938 (30.77%)	234.8M